dc.contributor.author | Rodriguez‑Mora, Sara | |
dc.contributor.author | De Wit, Flore | |
dc.contributor.author | García-Pérez, Javier | |
dc.contributor.author | Bermejo, Mercedes | |
dc.contributor.author | Lopez-Huertas, Maria Rosa | |
dc.contributor.author | Mateos, Elena | |
dc.contributor.author | Marti, Pilar | |
dc.contributor.author | Rocha, Susana | |
dc.contributor.author | Vigon-Hernandez, Lorena | |
dc.contributor.author | Christ, Frauke | |
dc.contributor.author | Debyser, Zeger | |
dc.contributor.author | Vílchez, Juan Jesús | |
dc.contributor.author | Coiras, Mayte | |
dc.contributor.author | Alcamí, José | |
dc.date.accessioned | 2019-10-07T08:06:59Z | |
dc.date.available | 2019-10-07T08:06:59Z | |
dc.date.issued | 2019-08 | |
dc.identifier.citation | PLoS Pathog. 2019 Aug 29;15(8):e1007958 | es_ES |
dc.identifier.issn | 1553-7374 | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/8481 | |
dc.description.abstract | The causative mutation responsible for limb girdle muscular dystrophy 1F (LGMD1F) is one heterozygous single nucleotide deletion in the stop codon of the nuclear import factor Transportin 3 gene (TNPO3). This mutation causes a carboxy-terminal extension of 15 amino acids, producing a protein of unknown function (TNPO3_mut) that is co-expressed with wild-type TNPO3 (TNPO3_wt). TNPO3 has been involved in the nuclear transport of serine/arginine-rich proteins such as splicing factors and also in HIV-1 infection through interaction with the viral integrase and capsid. We analyzed the effect of TNPO3_mut on HIV-1 infection using PBMCs from patients with LGMD1F infected ex vivo. HIV-1 infection was drastically impaired in these cells and viral integration was reduced 16-fold. No significant effects on viral reverse transcription and episomal 2-LTR circles were observed suggesting that the integration of HIV-1 genome was restricted. This is the second genetic defect described after CCR5Δ32 that shows strong resistance against HIV-1 infection. | es_ES |
dc.description.sponsorship | This work was supported by crowfunding site PRECIPITA from FECYT, the MERCKSALUD Foundation, the Spanish Ministry of Science (FIS PI12/00969; PI16CIII/00034; SAF2016-78480-R); the Spanish AIDS Research Network RD16CIII/0002/0001 that is included in Acción Estratégica en Salud, Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica 2016-2020, Instituto de Salud Carlos III, European Region Development Fund (FEDER); CIBERer-ISCIII (FIS PI16/00316) co-financed by the European Regional Development Founds (FEDER), IIS La Fe (2016-0388; 2018-0200), and Fundación Isabel Gemio (http://www.fundacionisabelgemio.com). The work of Dra. Sara Rodríguez-Mora is supported by the Asociación Conquistando Escalones, funded by Spanish LGMD1F patients and Sara Borrell grant from Instituto de Salud Carlos III. The work of Dra. María Rosa López-Huertas is financed by ISCIII-Subdirección General de Evaluación and European Funding for Regional Development (FEDER) and by Spanish Ministry of Economy and Competitiveness (PIE13/00040). The work of Elena Mateos is supported by the Spanish Ministry of Economy and Competitiveness SAF2016-78480-R. The work of Lorena Vigón is supported by a pre-doctoral grant from Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Public Library of Science (PLOS) | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.title | The mutation of Transportin 3 gene that causes limb girdle muscular dystrophy 1F induces protection against HIV-1 infection | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Atribución 4.0 Internacional | * |
dc.identifier.pubmedID | 31465518 | es_ES |
dc.format.volume | 15 | es_ES |
dc.format.number | 8 | es_ES |
dc.format.page | e1007958 | es_ES |
dc.identifier.doi | 10.1371/journal.ppat.1007958 | es_ES |
dc.contributor.funder | Fundación Española para la Ciencia y la Tecnología | |
dc.contributor.funder | MERCKSALUD Foundation | |
dc.contributor.funder | Ministerio de Ciencia, Innovación y Universidades (España) | |
dc.contributor.funder | RETICS-Sida (RIS-ISCIII) (España) | |
dc.contributor.funder | Instituto de Salud Carlos III | |
dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | |
dc.contributor.funder | Ministerio de Economía y Competitividad (España) | |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 1553-7374 | es_ES |
dc.relation.publisherversion | https://doi.org/10.1371/journal.ppat.1007958 | es_ES |
dc.identifier.journal | PLOS Pathogens | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/PI12/00969 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/PI16CIII/00034 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/SAF2016-78480-R | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/RD16CIII/0002/0001 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/PI16/00316 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/PIE13/00040 | es_ES |
dc.rights.accessRights | open access | es_ES |